Jointly provided by:	This activity is supported by an independent educational grant from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.
Tuesday, October 27, 2015. 6:00 PM - 8:00 PM ET Gaylord Palms Hotel & Convention Center Room Sun C Orlando, FL Please note: No additional fee is required to attend this CME/CPE activity; however, registration to AMCP Nexus 2015 is required.	Held in conjunction with AMCP Nexus 2015.
Click here to download the slides from this symposium.
Hot Topics Include: Assessing the clinical benefits of current and evolving rheumatoid arthritis (RA) therapies in a managed care setting Current practice guidelines review Current and emerging comparative effectiveness research (CER) for evidence-based treatment and benefit design decision making Assessing the value of current and emerging treatment options Maximizing value for current and emerging RA therapies
Distinguished Faculty Presenters
Jeffrey Dunn, PharmD, MBA Chief Clinical Officer Senior Vice President VRx Pharmacy Services, LLC Brian Kaye, MD, FACP Rheumatologist Sutter East Bay Medical Foundation Clinical Professor of Medicine University of California at San Francisco Adjunct Professor College of Education and Health Sciences Touro University Neil Minkoff, MD Principal, FountainHead    HealthCare Chief Medical Officer EmpiraMed, Inc. Fadia T. Shaya, PhD, MPH Professor and Vice-Chair for Academic Affairs PHSR University of Maryland School of Pharmacy
Who Should Attend? This activity is designed to meet the educational needs of managed care pharmacy directors, clinical pharmacists, quality directors, medical directors, members of AMCP, and other managed health care professionals attending AMCP Nexus 2015. Statement of Need/Program Overview Rheumatoid arthritis (RA) is an autoimmune disease affecting nearly 1.5 million adult Americans. There is no cure for RA, but new effective drugs are increasingly available to treat the disease and prevent deformed joints. Currently, the RA therapeutic pipeline is robust and includes agents that utilize novel mechanisms of action (MOAs) and various administration strategies (eg, oral, subcutaneous injection). The Managed Care Review BoardTM format features a review of important, relevant therapeutic category information and features peer-to-peer exchange between a diverse group of managed care and clinical specialist faculty contributors. This interactive program is designed to engage the faculty and audience to develop solutions for managed care professionals to implement within their own setting to improve outcomes for patients with RA. This approach supports managed care pharmacists by enhancing the results of their own health care organization's systematic literature reviews and analyses. Educational Objectives After completing this activity, the participant should be better able to: Discuss the current clinical practice guidelines to improve outcomes for patients with RA Explain the unique role and utility of CER to improve outcomes for the treatment of RA within a managed care setting Cite currently available RA data and interpret the results for enhanced managed care decision-making for the treatment of RA Apply the use of CER for the treatment of RA within a managed care setting Provide accurate and appropriate counsel as part of the managed care treatment team
Date and Time Tuesday, October 27, 2015 6:00 PM - 8:00 PM Gaylord Palms Hotel & Convention Center Room Sun C Orlando, FL Agenda 6:00 PM Dinner and Registration 6:05 PM Pre-Activity Learning Assessment and Opening Comments Neil Minkoff, MD 6:10 PM Assessing the Clinical Benefits of Current and Evolving RA Therapies in a Managed Care Setting Brian Kaye, MD 6:30 PM Current Practice Guidelines Review Neil Minkoff, MD 6:45 PM Faculty Idea Exchange 6:50 PM Current and Emerging CER for Evidence-Based Treatment and Benefit Design Decision Making Jeff Dunn, PharmD, MBA 7:05 PM Analyzing the Available Data to Assess the Value of Current and Emerging Treatment Options Fadia Shaya, PhD, MPH 7:25 PM Plan Benefit Designs: Maximizing Value for Current and Emerging RA Therapies Jeff Dunn, PharmD, MBA 7:40 PM Faculty Idea Exchange and Audience Q&A 7:55 PM Closing Comments Post-survey and Evaluations Neil Minkoff, MD
Physician Continuing Medical Education Accreditation Statement This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and Impact Education, LLC. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Pharmacist Continuing Education Accreditation Statement Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Credit Designation Postgraduate Institute for Medicine designates this continuing education activity for 2.0 contact hours (0.20 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number - (0809-9999-15-268-L01-P) Type of Activity: Application For Pharmacists: Upon receipt of a completed activity evaluation form, you will receive an email from the Postgraduate Institute for Medicine within 3 weeks with a link and directions to submit your credit to the NABP CPE Monitor Service.
Disclosure of Conflicts of Interest Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity. Americans with Disabilities Act Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812. Fee Information No additional fee is required to attend this CPE/CME activity. Please note: No additional fee is required to attend this CME/CPE activity; however, registration to AMCP Nexus 2015 is required. Pre-registration will close at 12:00 pm on October 26, 2015. Walk-in registration will be available at the time of the program. If you have any questions, please call (215) 619-8812 or email info@impactedu.net.